세계의 출혈성 질환 검사 시장 보고서(2025년)

Bleeding Disorder Testing Global Market Report 2025

US $ 4,490 ￦ 6,265,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,056,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,846,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

출혈성 질환 검사 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 7.9%의 연평균 복합 성장률(CAGR)로 220억 2,000만 달러 규모에 이를 것으로 예측됩니다. 예측 기간 동안의 성장은 혈우병의 유병률 증가, 출혈성 질환의 증상에 대한 인식 증가, 진단 연구에 대한 투자 증가, 세계 헬스케어 지출 증가, 희귀 출혈성 질환의 유병률 증가에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 기술 발전, 인공지능의 통합, 개인 맞춤형 의료, 원격 의료 서비스, 재택 검사 키트 등을 들 수 있습니다.

임상시험 증가는 향후 몇 년 동안 출혈성 질환 검사 시장의 성장을 가속할 것으로 예측됩니다. 임상시험은 인간을 대상으로 새로운 치료법, 치료법, 의약품, 기술의 안전성과 유효성을 평가하기 위한 조사이며, 그 수가 증가하는 추세입니다. 이러한 증가의 배경에는 의학 연구의 발전, 헬스케어 혁신에 대한 투자 증가, 새로운 치료법 및 치료법에 대한 수요 증가가 있습니다. 이러한 임상시험에서 출혈성 질환 검사는 출혈성 질환에 대한 새로운 약물 및 치료법의 효과와 안전성을 평가하고, 응고 이상을 관리 또는 교정하는 능력을 평가하고, 최적의 용량과 효과를 보장하기 위해 환자의 반응을 모니터링하는 데 매우 중요합니다. 예를 들어, 미국 임상시험 등록기관인 ClinicalTrials.gov에 따르면, 2023년 말까지 약 47만 7,228건의 임상시험이 등록되어 2022년의 43만 7,507건보다 증가할 것으로 예상하고 있습니다. 이처럼 임상시험 수 증가가 출혈성 질환 검사 시장의 확대를 견인하고 있습니다.

출혈성 질환 검사 시장의 주요 기업들은 장기적인 솔루션을 제공하고, 유전성 출혈성 질환을 치료하고, 치료 결과를 개선하고, 시장에서의 입지를 확대하기 위해 혈우병 B 유전자 치료와 같은 혁신적인 제품 개발에 주력하고 있습니다. 혈우병 B는 적절한 혈액 응고에 필요한 혈액응고인자 IX의 결핍을 특징으로 하는 출혈성 질환의 일종입니다. 혈우병 B 유전자 치료는 증상의 원인이 되는 근본적인 유전적 결함을 해결함으로써 장기적인 해결을 목표로 하는 새로운 치료법입니다. 예를 들어, 2023년 2월 호주에 본사를 둔 생명공학 기업 CSL Limited는 중증 및 중등도 혈우병 B형 혈우병 치료를 위한 최초이자 유일한 1회용 유전자 치료제인 HEMGENIX에 대해 유럽위원회로부터 조건부 판매 승인(CMA)을 획득했습니다. 이 혁신적인 치료법은 장기적인 효능을 제공하는 것을 목표로 하고 있으며, 정기적인 인자 보충 요법의 필요성을 줄이거나 없애고 혈우병 B 환자의 표준 치료에 큰 변화를 가져올 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 출혈성 질환 검사 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 출혈성 질환 검사 시장 : 성장률 분석
• 세계의 출혈성 질환 검사 시장 실적 : 규모와 성장, 2019-2024
• 세계의 출혈성 질환 검사 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 출혈성 질환 검사 전체 시장(TAM)

제6장 시장 세분화

• 세계의 출혈성 질환 검사 시장 : 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 시약 및 소모품
• 기기
• 세계의 출혈성 질환 검사 시장 적응증별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 혈우병 A
• 혈우병 B
• 폰빌레브란트병
• 특발성 혈소판 감소성 자반병
• 기타 적응증
• 세계의 출혈성 질환 검사 시장 치료 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 인자 보충 요법
• 약물 요법
• 세계의 출혈성 질환 검사 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원 및 진료소
• 진단센터
• 기타 최종사용자
• 세계의 출혈성 질환 검사 시장 : 시약 및 소모품 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 응고 시약
• 혈장 및 혈액 채취용 소모품
• 지혈 시약
• 인자 결핍 검사 키트
• 활성화 부분 트론보프라스틴 시간(APTT) 시약
• 세계의 출혈성 질환 검사 시장 : 악기 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 응고 분석 장비
• 혈소판 기능 분석 장비
• 지혈 검사기기
• POC(Point of Care) 검사 장비
• 자동 혈액 검사 시스템

제7장 지역별/국가별 분석

• 세계의 출혈성 질환 검사 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 출혈성 질환 검사 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 출혈성 질환 검사 시장 : 경쟁 구도
• 출혈성 질환 검사 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Siemens Healthcare GmbH
• Baxter International Inc.
• CSL Limited
• Octapharma AG
• HORIBA Ltd.
• Haemonetics Corporation
• Diagnostica Stago S.A.S.
• Sekisui Diagnostics LLC
• Helena Laboratories Corporation
• LFB Group
• Sysmex Inostics GmbH
• Medexus Pharmaceuticals Inc.
• Precision Biologics Inc.
• Corgenix Inc.
• Diapharma Group Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 출혈성 질환 검사 시장(2029년) : 새로운 기회를 제공하는 국가
• 출혈성 질환 검사 시장(2029년) : 새로운 기회를 제공하는 부문
• 출혈성 질환 검사 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Bleeding disorder testing encompasses a variety of diagnostic methods aimed at assessing the function and composition of blood to detect abnormalities associated with bleeding disorders. These tests evaluate clotting ability, platelet function, and specific deficiencies or dysfunctions of clotting factors.

The primary product categories for bleeding disorder testing are reagents and consumables, as well as instruments. The reagents and consumables segment includes the chemical substances, materials, and disposable items utilized in the diagnosis and analysis of bleeding disorders. This category features test kits, reagents, and other necessary supplies for performing these tests. Common indications for these tests include hemophilia A, hemophilia B, von Willebrand disease, idiopathic thrombocytopenic purpura, among others. Treatments generally involve factor replacement therapy and drug therapy, and the tests are used by various end-users, such as hospitals, clinics, and diagnostic centers.

The bleeding disorder testing market research report is one of a series of new reports from The Business Research Company that provides bleeding disorder testing market statistics, including bleeding disorder testing industry global market size, regional shares, competitors with a bleeding disorder testing market share, detailed bleeding disorder testing market segments, market trends, and opportunities, and any further data you may need to thrive in the bleeding disorder testing industry. This bleeding disorder testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bleeding disorder testing market size has grown strongly in recent years. It will grow from $14.99 billion in 2024 to $16.23 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to the increasing prevalence of bleeding disorders, increasing investment in research and development, a growing number of specialized clinics, increasing demand for early diagnosis, and a rising number of clinical trials.

The bleeding disorder testing market size is expected to see strong growth in the next few years. It will grow to $22.02 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to the increasing prevalence of hemophilia rising awareness of bleeding disorder symptoms, increasing investment in diagnostic research, rising healthcare spending globally, and rising prevalence of rare bleeding disorders. Major trends in the forecast period include technological advancements, integration of artificial intelligence, personalized medicine, telemedicine services, and home-based testing kits.

The increasing number of clinical trials is anticipated to boost the growth of the bleeding disorder testing market in the coming years. Clinical trials, which are research studies that evaluate the safety and effectiveness of new medical treatments, therapies, medicines, or technologies in humans, are on the rise. This increase is driven by advancements in medical research, growing investment in healthcare innovation, and the rising demand for new treatments and therapies. In these trials, bleeding disorder testing is crucial for assessing the efficacy and safety of new medicines and therapies for bleeding disorders, evaluating their ability to manage or correct clotting abnormalities, and monitoring patient responses to ensure optimal dosing and effectiveness. For example, according to ClinicalTrials.gov, a US-based clinical trial registry, approximately 477,228 clinical trials were registered by the end of 2023, up from 437,507 in 2022. Thus, the growing number of clinical trials is propelling the bleeding disorder testing market's expansion.

Leading companies in the bleeding disorder testing market are focusing on developing innovative products, such as gene therapy for Hemophilia B, to provide long-term solutions, cure genetic bleeding disorders, improve treatment outcomes, and broaden their market presence. Hemophilia B, characterized by a deficiency of clotting factor IX necessary for proper blood coagulation, is a specific type of bleeding disorder. Gene therapy for Hemophilia B is an emerging treatment that aims to offer a long-term solution by addressing the underlying genetic defect causing the condition. For instance, in February 2023, CSL Limited, an Australia-based biotechnology company, received conditional marketing authorization (CMA) from the European Commission for HEMGENIX, the first and only one-time gene therapy for treating severe and moderately severe Hemophilia B. This innovative treatment aims to provide long-lasting efficacy, potentially reducing or eliminating the need for regular factor replacement therapy and significantly altering the standard of care for Hemophilia B patients.

In May 2022, Sema4, a US-based company specializing in genetic testing and data-driven patient insights, acquired GeneDx, LLC for $150 million. This acquisition aims to enhance Sema4's genetic testing capabilities by integrating GeneDx's expertise in genetic diagnostics for rare and inherited disorders, including bleeding disorders. GeneDx LLC, also based in the US, offers testing related to bleeding disorders as part of its comprehensive genetic diagnostic services.

Major companies operating in the bleeding disorder testing market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Siemens Healthcare GmbH, Baxter International Inc., CSL Limited, Octapharma AG, HORIBA Ltd., Haemonetics Corporation, Diagnostica Stago S.A.S., Sekisui Diagnostics LLC, Helena Laboratories Corporation, LFB Group, Sysmex Inostics GmbH, Medexus Pharmaceuticals Inc., Precision Biologics Inc., Corgenix Inc., Diapharma Group Inc., Hyphen BioMed, Hema Biologics LLC

North America was the largest region in the bleeding disorder testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bleeding disorder testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bleeding disorder testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bleeding disorder testing market consists of revenues earned by entities by providing services such as complete blood count (CBC), prothrombin time (PT), activated partial thromboplastin time (aPTT), and genetic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The bleeding disorder testing market also includes sales of coagulation analyzers, platelet aggregation analyzers, blood collection devices, genetic testing kits, and bleeding time test kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bleeding Disorder Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bleeding disorder testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bleeding disorder testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bleeding disorder testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Reagents And Consumables; Instruments
• 2) By Indication: Hemophilia A; Hemophilia B; Von Willebrand Disease; Idiopathic Thrombocytopenic Purpura; Other Indications
• 3) By Treatment Type: Factor Replacement Therapy; Drug Therapy
• 4) By End User: Hospitals And Clinics; Diagnostic Centers; Other End Users
• Subsegments:
• 1) By Reagents And Consumables: Coagulation Reagents; Plasma And Blood Collection Consumables; Hemostasis Reagents; Factor Deficiency Assay Kits; Activated Partial Thromboplastin Time (APTT) Reagents
• 2) By Instruments: Coagulation Analyzers; Platelet Function Analyzers; Hemostasis Testing Instruments; Point-Of-Care Testing Devices; Automated Blood Testing Systems
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited; Novo Nordisk A/S
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bleeding Disorder Testing Market Characteristics

3. Bleeding Disorder Testing Market Trends And Strategies

4. Bleeding Disorder Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Bleeding Disorder Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bleeding Disorder Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bleeding Disorder Testing Market Growth Rate Analysis
• 5.4. Global Bleeding Disorder Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bleeding Disorder Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bleeding Disorder Testing Total Addressable Market (TAM)

6. Bleeding Disorder Testing Market Segmentation

• 6.1. Global Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Consumables
• Instruments
• 6.2. Global Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hemophilia A
• Hemophilia B
• Von Willebrand Disease
• Idiopathic Thrombocytopenic Purpura
• Other Indications
• 6.3. Global Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Factor Replacement Therapy
• Drug Therapy
• 6.4. Global Bleeding Disorder Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Centers
• Other End Users
• 6.5. Global Bleeding Disorder Testing Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coagulation Reagents
• Plasma And Blood Collection Consumables
• Hemostasis Reagents
• Factor Deficiency Assay Kits
• Activated Partial Thromboplastin Time (APTT) Reagents
• 6.6. Global Bleeding Disorder Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coagulation Analyzers
• Platelet Function Analyzers
• Hemostasis Testing Instruments
• Point-Of-Care Testing Devices
• Automated Blood Testing Systems

7. Bleeding Disorder Testing Market Regional And Country Analysis

• 7.1. Global Bleeding Disorder Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bleeding Disorder Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bleeding Disorder Testing Market

• 8.1. Asia-Pacific Bleeding Disorder Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bleeding Disorder Testing Market

• 9.1. China Bleeding Disorder Testing Market Overview
• 9.2. China Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bleeding Disorder Testing Market

• 10.1. India Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bleeding Disorder Testing Market

• 11.1. Japan Bleeding Disorder Testing Market Overview
• 11.2. Japan Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bleeding Disorder Testing Market

• 12.1. Australia Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bleeding Disorder Testing Market

• 13.1. Indonesia Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bleeding Disorder Testing Market

• 14.1. South Korea Bleeding Disorder Testing Market Overview
• 14.2. South Korea Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bleeding Disorder Testing Market

• 15.1. Western Europe Bleeding Disorder Testing Market Overview
• 15.2. Western Europe Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bleeding Disorder Testing Market

• 16.1. UK Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bleeding Disorder Testing Market

• 17.1. Germany Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bleeding Disorder Testing Market

• 18.1. France Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bleeding Disorder Testing Market

• 19.1. Italy Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bleeding Disorder Testing Market

• 20.1. Spain Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bleeding Disorder Testing Market

• 21.1. Eastern Europe Bleeding Disorder Testing Market Overview
• 21.2. Eastern Europe Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bleeding Disorder Testing Market

• 22.1. Russia Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bleeding Disorder Testing Market

• 23.1. North America Bleeding Disorder Testing Market Overview
• 23.2. North America Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bleeding Disorder Testing Market

• 24.1. USA Bleeding Disorder Testing Market Overview
• 24.2. USA Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bleeding Disorder Testing Market

• 25.1. Canada Bleeding Disorder Testing Market Overview
• 25.2. Canada Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bleeding Disorder Testing Market

• 26.1. South America Bleeding Disorder Testing Market Overview
• 26.2. South America Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bleeding Disorder Testing Market

• 27.1. Brazil Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bleeding Disorder Testing Market

• 28.1. Middle East Bleeding Disorder Testing Market Overview
• 28.2. Middle East Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bleeding Disorder Testing Market

• 29.1. Africa Bleeding Disorder Testing Market Overview
• 29.2. Africa Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bleeding Disorder Testing Market Competitive Landscape And Company Profiles

• 30.1. Bleeding Disorder Testing Market Competitive Landscape
• 30.2. Bleeding Disorder Testing Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

31. Bleeding Disorder Testing Market Other Major And Innovative Companies

• 31.1. Siemens Healthcare GmbH
• 31.2. Baxter International Inc.
• 31.3. CSL Limited
• 31.4. Octapharma AG
• 31.5. HORIBA Ltd.
• 31.6. Haemonetics Corporation
• 31.7. Diagnostica Stago S.A.S.
• 31.8. Sekisui Diagnostics LLC
• 31.9. Helena Laboratories Corporation
• 31.10. LFB Group
• 31.11. Sysmex Inostics GmbH
• 31.12. Medexus Pharmaceuticals Inc.
• 31.13. Precision Biologics Inc.
• 31.14. Corgenix Inc.
• 31.15. Diapharma Group Inc.

32. Global Bleeding Disorder Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bleeding Disorder Testing Market

34. Recent Developments In The Bleeding Disorder Testing Market

35. Bleeding Disorder Testing Market High Potential Countries, Segments and Strategies

• 35.1 Bleeding Disorder Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bleeding Disorder Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bleeding Disorder Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료